Jazz Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.About JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.
JAZZ Key Statistics
Stock Snapshot
As of today, Jazz Pharmaceuticals(JAZZ) shares are valued at $244.54. The company's market cap stands at 15.87B, with a P/E ratio of 16.86.
During the trading session on 2026-08-29, Jazz Pharmaceuticals(JAZZ) shares reached a daily high of $250.64 and a low of $244.49. At a current price of $244.54, the stock is +0.0% higher than the low and still -2.4% under the high.
Trading activity shows a volume of 1.19M, compared to an average daily volume of 1.28M.
The stock's 52-week range extends from a low of $123.88 to a high of $266.38.
The stock's 52-week range extends from a low of $123.88 to a high of $266.38.
JAZZ News
Jazz Pharmaceuticals (JAZZ) announced the pricing of $1.1 billion aggregate principal amount of 1.875% exchangeable senior notes due 2032 in a private offering...
Jazz Pharmaceuticals has doubled in the past year, yet the valuation checks send a more muted signal, with the stock screening as undervalued on earnings multip...
Jazz Pharmaceuticals JAZZ announced that the FDA has approved a label expansion of its marketed drug, Ziihera (zanidatamab-hrii), for the first-line treatment o...
Analyst ratings
90%
of 21 ratingsMore JAZZ News
The U.S. Food and Drug Administration (FDA), on Tuesday, approved Jazz Pharmaceuticals plc’s (NASDAQ:JAZZ) two Ziihera-containing combination regimens as first-...
On Tuesday, the U.S. Food and Drug Administration (FDA) approved Jazz Pharmaceuticals plc’s (NASDAQ:JAZZ) two Ziihera-containing combination regimens as first-l...
The latest update is out from Zymeworks ( (ZYME) ). Zymeworks Inc. reported that its partner Jazz Pharmaceuticals has secured U.S. Food and Drug Administration...
Zymeworks (ZYME) announced that its partner, Jazz Pharmaceuticals, has received U.S. Food and Drug Administration approval for two Ziihera-containing regimens f...
Jazz Pharmaceuticals (JAZZ) announced that the U.S. FDA approved two Ziihera-containing regimens for the first-line treatment of adults with unresectable locall...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.